Please E-mail suggested additions, comments and/or corrections to Kent@MoreLaw.Com.
Help support the publication of case reports on MoreLaw
United States of America v. Public Drug Company, d/b/a Booneville Discount Drugs
Date: 04-26-2021
Case Number:
Judge:
Court: United States District Court for the Eastern District of Kentucky (Urban county)
Plaintiff's Attorney: United States District Attorney’s Office
Defendant's Attorney:
Criminal Defense Lawyer Directory
Criminal Defense Lawyer Directory
Description:
Lexington, Kentucky criminal defense lawyer represented defendant charged with violating the Controlled Substance Act ("CSA").
Public Drug Company, d/b/a Booneville Discount Drugs, a Booneville, Kentucky pharmacy agreed to pay the United States $250,000 to settle civil allegations that it failed to make and maintain complete and accurate records of its controlled substances, in violation of the federal Controlled Substances Act ("CSAâ€).
Under the CSA, pharmacies authorized to possess controlled substances are required to maintain complete and accurate records of each controlled substance received, dispensed, and disposed. The U.S. Drug Enforcement Administration ("DEAâ€) has the authority to inspect the records of these pharmacies and verify that their controlled substances records are complete and accurate in compliance with the CSA.
The United States alleged that Booneville Discount Drugs failed to maintain complete and accurate records of its controlled substances inventories from November 25, 2016 to April 25, 2018. In an audit performed by the DEA, Booneville Discount Drugs' records did not account for observed shortages of oxycodone and methadone in its inventories during this time period. Booneville Discount Drugs also self-disclosed its recordkeeping discrepancies of controlled substances to the DEA.
The Government's work in this investigation illustrates its commitment to combatting violations of controlled substances laws. Tips from all sources about possible violations of controlled substances laws can be reported to the DEA at www.dea.gov/submit-tip.
The DEA, Diversion Control Division conducted the investigation of alleged violations. Assistant United States Attorney Meghan Stubblebine represented the United States. The claims resolved by the settlement are allegations only, and there has been no determination of liability.
Public Drug Company, d/b/a Booneville Discount Drugs, a Booneville, Kentucky pharmacy agreed to pay the United States $250,000 to settle civil allegations that it failed to make and maintain complete and accurate records of its controlled substances, in violation of the federal Controlled Substances Act ("CSAâ€).
Under the CSA, pharmacies authorized to possess controlled substances are required to maintain complete and accurate records of each controlled substance received, dispensed, and disposed. The U.S. Drug Enforcement Administration ("DEAâ€) has the authority to inspect the records of these pharmacies and verify that their controlled substances records are complete and accurate in compliance with the CSA.
The United States alleged that Booneville Discount Drugs failed to maintain complete and accurate records of its controlled substances inventories from November 25, 2016 to April 25, 2018. In an audit performed by the DEA, Booneville Discount Drugs' records did not account for observed shortages of oxycodone and methadone in its inventories during this time period. Booneville Discount Drugs also self-disclosed its recordkeeping discrepancies of controlled substances to the DEA.
The Government's work in this investigation illustrates its commitment to combatting violations of controlled substances laws. Tips from all sources about possible violations of controlled substances laws can be reported to the DEA at www.dea.gov/submit-tip.
The DEA, Diversion Control Division conducted the investigation of alleged violations. Assistant United States Attorney Meghan Stubblebine represented the United States. The claims resolved by the settlement are allegations only, and there has been no determination of liability.
Outcome:
Booneville Pharmacy Agrees to Pay $250,000 to Resolve Alleged Violations of the Controlled Substances Act.
Plaintiff's Experts:
Defendant's Experts:
Comments:
About This Case
What was the outcome of United States of America v. Public Drug Company, d/b/a Bo...?
The outcome was: Booneville Pharmacy Agrees to Pay $250,000 to Resolve Alleged Violations of the Controlled Substances Act.
Which court heard United States of America v. Public Drug Company, d/b/a Bo...?
This case was heard in United States District Court for the Eastern District of Kentucky (Urban county), KY.
Who were the attorneys in United States of America v. Public Drug Company, d/b/a Bo...?
Plaintiff's attorney: United States District Attorney’s Office. Defendant's attorney: Criminal Defense Lawyer Directory.
When was United States of America v. Public Drug Company, d/b/a Bo... decided?
This case was decided on April 26, 2021.